Pendulum Therapeutics

13 articles about Pendulum Therapeutics

• Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer

  1/9/2024

  Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.

• Halle Berry, Long-Standing Pendulum Customer, Joins Company as Chief Communications Officer, and Becomes Equity Owner and Investor

  2/9/2023

  Pendulum Therapeutics announced that Halle Berry, Academy Award® winning actress and director, has joined the company as equity owner, investor and Chief Communications Officer.

• Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila, a Key Strain Forging a Path for the Future of Probiotics

  6/10/2022

  Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila , a Key Strain Forging a Path for the Future of Probiotics.

• Pendulum Therapeutics Provides Leadership in Microbiome Education among Healthcare Professionals

  10/28/2021

  Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the microbiome and its relationship to metabolic disease, including type 2 diabetes.

• New Report Explains Microbiome Impact on Glucose Control

  6/28/2021

  A new study by Pendulum Therapeutics was presented at the American Diabetes Association's 81st Scientific Sessions, the preeminent global conference for diabetes clinicians, researchers, and professionals where cutting-edge science and advances in diabetes research, prevention, and care are discussed.

• Pendulum Therapeutics Raises $54 Million to Meet Surging Customer Demand

  4/7/2021

  Strong Loyalty Among Subscribers: After Five Months, 74% of Key Customer Segment Remain Active Users Company Created New Product Category, Filling Market Gap Between Supplements and Prescription Drugs

• Survey Uncovers the Straight Poop about America's Potty Habits

  11/17/2020

  The year 2020, commonly referred to as a "total sh!# show," has led Pendulum Therapeutics – makers of a probiotic that helps the body process fiber – to ask some questions.

• Pendulum Therapeutics Announces Publication Of Clinical Data For First-Ever Medical Probiotic That Provides The Dietary Management Of Healthy A1C And Blood Glucose Levels

  7/20/2020

  Pioneering Microbiome Company Demonstrates Significant Clinical Results from Use of Microbiome-Based Synbiotic in Patients with Type 2 Diabetes

• Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes

  6/4/2020

  Pendulum Therapeutics , a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced today the launch of Pendulum Glucose Control, the first and only medical probioti

• Pendulum Therapeutics CEO Colleen Cutcliffe Joins American Diabetes Association Northern California Leadership Board

  5/26/2020

  Pendulum Therapeutics, an evidence-based microbiome company, is proud to announce that CEO and Co-Founder Colleen Cutcliffe, Ph.D., has accepted an invitation to join the Leadership Board of the American Diabetes Association, Northern California chapter.

• PENDULUM THERAPEUTICS ADDS GLOBAL HEALTH CARE EXECUTIVE HEATHER MASON TO BOARD OF DIRECTORS

  3/30/2020

  Pendulum Therapeutics , an evidence-based microbiome company, announced today that veteran health care executive Heather Mason has joined its board of directors. A global executive with more than 25 years of experience in bringing novel pharmaceutical and consumer products to battle chronic diseases, including diabetes, Mason brings a wealth of expertise to Pendulum Therapeutics’ fast-growing business. Mason most recently served as executi

• Pendulum Therapeutics Announces Formation of Scientific and Medical Advisory BoardsGlobally Recognized Metabolic Experts and Industry Luminaries Underscore Pendulum’s Foundation of Scientific Rigor and Medical Innovation

  1/21/2020

  Pendulum Therapeutics, an evidence-based microbiome company, announced today the formation of its Scientific Advisory Board (SAB) and Medical Advisory Board (MAB).

• Pendulum Therapeutics to Receive the 2019 Pantheon DiNA Rising Star Award from CLSA Distinguished Pantheon Awards program honors innovation and excellence in companies and individuals dedicated to enhancing California life sciences

  10/31/2019

  Pendulum Therapeutics announced that the California Life Sciences Association has awarded it the 2019 Pantheon DiNA™ Award for Rising Star.